AMYLYX PHARMACEUTICALS INC

Ticker: AMLX CUSIP: 03237H101 Class: Common Stock

MetLife Investment Management, LLC's Holding History (CIK: 0001529735)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 49,654 Value ($000) $600 Avg Close $13.58 Range $11.69 - $16.96
Q3 2025
Shares 42,929 Value ($000) $583 Avg Close $9.41 Range $5.97 - $15.14
Q2 2025
Shares 42,929 Value ($000) $275 Avg Close $4.86 Range $3.11 - $6.70
Q1 2024
Shares 13,768 Value ($000) $39 Avg Close $13.08 Range $2.67 - $19.95
Q4 2023
Shares 26,712 Value ($000) $393 Avg Close $15.33 Range $11.82 - $18.88
Q3 2023
Shares 26,712 Value ($000) $489 Avg Close $21.15 Range $17.80 - $25.48
Q2 2023
Shares 26,712 Value ($000) $576 Avg Close $27.01 Range $20.79 - $31.77
Q1 2023
Shares 26,712 Value ($000) $784 Avg Close $34.74 Range $26.64 - $41.93
Q4 2022
Shares 26,712 Value ($000) $987 Avg Close $35.49 Range $28.13 - $39.77
Q3 2022
Shares 19,461 Value ($000) $548 Avg Close $24.95 Range $15.80 - $32.80
Q2 2022
Shares 6,785 Value ($000) $131 Avg Close $11.87 Range $6.51 - $20.74
Q1 2022
Shares 6,785 Value ($000) $87 Avg Close $22.45 Range $10.49 - $33.41